The two cysteine residues at positions 7 and 14 form an intramolecular disulfide bond that creates a small cyclic loop within the 16-residue chain
For oral administration, clinical trials have studied doses ranging from 1-30 mg daily, with typical protocols using 1-2 mg per dose on an empty stomach
Gene Expression Analysis Gene expression analysis revealed overlapping patterns between ketamine and BPC-157 effects on Nos1 (neuronal NOS), Nos2 (inducible NOS), Plcg1, Prkcg, and Ptgs2 (COX-2)
That said, InfiniWell is dedicated to ensuring the safety and efficacy of its products by following Good Manufacturing Practices (GMP) and conducting third-party testing
Future Directions in BPC-157 Synthesis As research into BPC-157 continues to evolve, new synthesis methods and applications are likely to emerge: Exploration of alternative synthesis methods, such as enzymatic peptide synthesis or native chemical ligation, which could potentially improve yields or reduce costs